The ASGR1 Knockout HeLa Polyclonal Cells are a CRISPR/Cas9-edited polyclonal knockout cell population derived from the HeLa cell line, designed to disrupt the human ASGR1 gene. This loss-of-function model abolishes expression of the asialoglycoprotein receptor major subunit, thereby enabling detailed investigation of ASGR1-dependent cellular processes. The polyclonal format retains genetic diversity, ensuring that functional assays reflect population-level responses rather than monoclonal artifacts.
HeLa cells, an immortalized epithelial line derived from a cervical adenocarcinoma, are HPV18-positive and have been a cornerstone of biomedical research for decades. Their robust proliferation, ease of transfection, and well-documented endocytic pathways make them an ideal host for gene-editing studies. This background enables rigorous examination of receptor-mediated internalization and lysosomal degradation processes, providing a reliable context for investigating how ASGR1 disruption affects these pathways.
ASGR1 encodes the major subunit of the asialoglycoprotein receptor (ASGPR), a C-type lectin that forms a calcium-dependent hetero-oligomeric complex with ASGR2 on the plasma membrane. Upon binding desialylated glycoprotein ligands, the receptor-ligand complex is rapidly internalized via clathrin-mediated endocytosis, facilitated by adaptor proteins including the AP2 complex and ??-arrestin. The complex then transits through early endosomes before being delivered to lysosomes for degradation. Transcription of ASGR1 is controlled by hepatocyte nuclear factors HNF4?? and HNF1??, as well as C/EBP??, integrating metabolic signals. Downstream, loss of ASGR1 function leads to stabilization of the low-density lipoprotein receptor (LDLR), increasing its cell-surface expression and enhancing clearance of circulating non-HDL cholesterol; additionally, ASGR1 participates in the removal of apoptotic cells.
Although ASGR1 is predominantly expressed in hepatocytes, HeLa cells possess the core endocytic machinery necessary to support ASGPR function, enabling dissection of receptor-mediated ligand uptake and intracellular trafficking in a simplified, non-hepatic model. This knockout system allows researchers to investigate the molecular determinants of ASGR1-dependent endocytosis, such as the roles of calcium ions, ASGR2 heteromerization, and clathrin adaptor recruitment, without confounding liver-specific regulatory inputs. It serves as a valuable tool for studying C-type lectin receptor biology and glycoprotein clearance mechanisms in a well-characterized epithelial background.
Typical applications include functional endocytosis assays using fluorescently labeled asialoorosomucoid to measure ligand uptake, co-immunoprecipitation to map interactions with ASGR2 and clathrin adaptors, and immunofluorescence to visualize receptor trafficking. The cells are suitable for screening small-molecule modulators of ASGPR activity and for cholesterol metabolism studies when complemented with LDLR expression constructs. Standard characterization by Western blotting and RT?qPCR verifies target knockout. For further technical information, please contact Ascent Research.
